5 completed, 1 terminated. 3 Phase 1, 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 3 | 2 | Completed 1, Terminated 1 |
| Phase 2 | 1 | Completed 1 |
Follow GSK221149A: new trials by email Literature Review of GSK221149A trials Research Report on GSK221149A
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Follow up Study to Assess Long Term Safety and Outcomes in Infants and Children Born to Mothers Participating in Retosiban Treatment Studies Retosiban, Atosiban, Placebo - Obstetric Labour, Premature | Phase 3 | Completed | GlaxoSmithKline | 98 | 2015-06-01 | 2020-07-09 |
| A Randomized Study Comparing the Efficacy and Safety of Retosiban Versus Atosiban for Women in Spontaneous Preterm Labour Retosiban, Atosiban, Placebo matching retosiban - Obstetric Labour, Premature | Phase 3 | Terminated | GlaxoSmithKline | 97 | 2015-03-16 | 2020-07-29 |
| A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Retosiban (GSK221149) When Dosed With Efavirenz (EFZ) Retosiban, EFZ 600 mg - Obstetric Labour, Premature | Phase 1 | Completed | GlaxoSmithKline | 18 | 2013-06-11 | 2017-05-11 |
| This Study Will Investigate the Effect of Single Oral Doses of Retosiban on Cardiac Repolarization, With Moxifloxacin as a Positive Control in Healthy Volunteers. Retosiban 100 mg, Retosiban 800 mg, Placebo - Obstetric Labour, Premature | Phase 1 | Completed | GlaxoSmithKline | 52 | 2012-10-03 | 2017-06-12 |
| The Safety, Tolerability And Metabolism Of GSK221149A, In Pregnant Women (30-36 Weeks), In Pre-Term Labor GSK221149A, Placebo - Obstetric Labour, Premature | Phase 2 | Completed | GlaxoSmithKline | 93 | 2007-10-12 | 2018-01-16 |
| Absorption, Distribution, Metabolism And Excretion Study For GSK221149A GSK221149A - Obstetric Labour, Premature, Premature Labor | Phase 1 | Completed | GlaxoSmithKline | 6 | 2006-10-01 | 2012-03-19 |
Premature Birth (6) · Obstetric Labor, Premature (3)
GlaxoSmithKline (6)
United States (5) · South Korea (3) · Spain (3) · United Kingdom (3) · Belgium (2) · Germany (2) · Israel (2) · Italy (2) · Mexico (2) · Sweden (2) · Argentina (1) · Bulgaria (1) · Colombia (1) · France (1) · Japan (1)
2014 (1)